|
C18ORF54 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.52969999999542E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.817900E-04 |
| Normal-vs-Stage2 |
1.781950E-04 |
| Normal-vs-Stage3 |
2.541500E-03 |
| Normal-vs-Stage4 |
7.207400E-04 |
| Stage1-vs-Stage2 |
1.830040E-01 |
| Stage1-vs-Stage3 |
7.655800E-01 |
| Stage1-vs-Stage4 |
3.171200E-01 |
| Stage2-vs-Stage3 |
3.551400E-01 |
| Stage2-vs-Stage4 |
7.918000E-01 |
| Stage3-vs-Stage4 |
5.749600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.627400E-04 |
| Normal-vs-AfricanAmerican |
6.462100E-03 |
| Normal-vs-Asian |
3.604300E-03 |
| Caucasian-vs-AfricanAmerican |
5.033400E-01 |
| Caucasian-vs-Asian |
7.958600E-01 |
| AfricanAmerican-vs-Asian |
6.497800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.320690E-03 |
| Normal-vs-Female |
4.13750000000102E-05 |
| Male-vs-Female |
5.572200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.579280E-03 |
| Normal-vs-Age(41-60Yrs) |
1.83642000000095E-05 |
| Normal-vs-Age(61-80Yrs) |
3.774900E-04 |
| Normal-vs-Age(81-100Yrs) |
7.799600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.152040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.642210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.306200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.647200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.325500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.356230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.116000E-01 |
| Classical-VS-Follicular |
4.557100E-03 |
| Classical-VS-Other |
7.117400E-01 |
| Classical-VS-Normal |
6.388200E-04 |
| Tall-VS-Follicular |
1.166380E-01 |
| Tall-VS-Other |
6.777000E-01 |
| Tall-VS-Normal |
1.270990E-01 |
| Follicular-VS-Other |
5.642200E-01 |
| Follicular-VS-Normal |
7.8096000000194E-07 |
| Other-VS-Normal |
1.294380E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.72680000004788E-06 |
| Normal-vs-N1 |
6.717400E-03 |
| N0-vs-N1 |
3.609400E-01 |
|
|
